{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T19:39:06Z","timestamp":1779392346040,"version":"3.53.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","liver.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.cld.2015.08.011","type":"journal-article","created":{"date-parts":[[2015,10,26]],"date-time":"2015-10-26T05:46:14Z","timestamp":1445838374000},"page":"191-203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Liver Transplantation for Cholestatic Liver Diseases in Adults"],"prefix":"10.1016","volume":"20","author":[{"given":"Vandana","family":"Khungar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Seth","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cld.2015.08.011_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840100102","article-title":"Prognosis in primary biliary cirrhosis: model for decision making","volume":"10","author":"Dickson","year":"1989","journal-title":"Hepatology"},{"issue":"26","key":"10.1016\/j.cld.2015.08.011_bib2","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1056\/NEJM198906293202602","article-title":"Efficiency of liver transplantation in patients with primary biliary cirrhosis","volume":"320","author":"Markus","year":"1989","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.cld.2015.08.011_bib3","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1136\/gut.31.9.1069","article-title":"Referral of patients with primary biliary cirrhosis for liver transplantation","volume":"31","author":"Neuberger","year":"1990","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.cld.2015.08.011_bib4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.08.011_bib5","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.cld.2008.02.015","article-title":"Liver transplantation in primary biliary cirrhosis","volume":"12","author":"Milkiewicz","year":"2008","journal-title":"Clin Liver Dis"},{"issue":"4","key":"10.1016\/j.cld.2015.08.011_bib6","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/cld.341","article-title":"Recurrence of autoimmune hepatitis, primary biliary cirrhosis, and primary sclerosing cholangitis after transplantation","volume":"3","author":"Harnois","year":"2014","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cld.2015.08.011_bib7","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1002\/lt.21916","article-title":"Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis after liver transplantation","volume":"S2","author":"Duclos-Vallee","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2015.08.011_bib8","series-title":"Transplantation of the liver","first-page":"159","article-title":"Transplantation for primary biliary cirrhosis","author":"Imam","year":"2015"},{"issue":"11","key":"10.1016\/j.cld.2015.08.011_bib9","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1111\/j.1600-6143.2011.03738.x","article-title":"Regional variability in symptom-based MELD exceptions: a response to organ shortage?","volume":"11","author":"Argo","year":"2011","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.cld.2015.08.011_bib10","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/hep.510290229","article-title":"Quality of life before and after liver transplantation for cholestatic liver disease","volume":"29","author":"Gross","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.08.011_bib11","doi-asserted-by":"crossref","first-page":"S-1032","DOI":"10.1016\/S0016-5085(15)33530-7","article-title":"Patients with primary biliary cirrhosis have the highest wait-list mortality","volume":"148","author":"Kaif","year":"2015","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cld.2015.08.011_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1432-2277.2011.01336.x","article-title":"Long-term outcome of living donor liver transplantation for primary biliary cirrhosis","volume":"25","author":"Kaneko","year":"2012","journal-title":"Transpl Int"},{"issue":"10","key":"10.1016\/j.cld.2015.08.011_bib13","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/lt.23704","article-title":"Liver transplantation and autoimmune liver diseases","volume":"19","author":"Liberal","year":"2013","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1016\/j.cld.2015.08.011_bib14","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.transproceed.2008.10.095","article-title":"Liver transplantation for primary biliary cirrhosis: results of aggressive corticosteroid withdrawal","volume":"41","author":"Campsen","year":"2009","journal-title":"Transplant Proc"},{"issue":"10","key":"10.1016\/j.cld.2015.08.011_bib15","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1053\/jlts.2003.50213","article-title":"Recurrence of primary biliary cirrhosis after liver transplantation: histologic estimate of incidence and natural history","volume":"9","author":"Sylvestre","year":"2003","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.cld.2015.08.011_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1665-2681(19)31659-X","article-title":"Anti-parietal cell autoantibodies (PCA) in primary biliary cirrhosis: a putative marker for recurrence after orthotopic liver transplantation?","volume":"9","author":"Ciesek","year":"2010","journal-title":"Ann Hepatol"},{"issue":"9","key":"10.1016\/j.cld.2015.08.011_bib17","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/lt.21124","article-title":"Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation","volume":"13","author":"Charatcharoenwitthaya","year":"2007","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.cld.2015.08.011_bib18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.cld.2012.12.005","article-title":"Liver transplant for cholestatic liver diseases","volume":"17","author":"Carrion","year":"2013","journal-title":"Clin Liver Dis"},{"issue":"5","key":"10.1016\/j.cld.2015.08.011_bib19","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1053\/jhep.2000.19067","article-title":"Reliability and validity of the NIDDK-QA instrument in the assessment of quality of life in ambulatory patients with cholestatic liver disease","volume":"32","author":"Kim","year":"2000","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2015.08.011_bib20","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/lt.24079","article-title":"Use of model for end-stage liver disease exceptions for donation after cardiac death graft recipients relisted for liver transplantation","volume":"21","author":"Maduka","year":"2015","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.cld.2015.08.011_bib21","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/hep.26972","article-title":"Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation","volume":"59","author":"Martin","year":"2014","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.cld.2015.08.011_bib22","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.cgh.2014.02.008","article-title":"Low risk of hepatocellular carcinoma in patients with primary sclerosing cholangitis with cirrhosis","volume":"12","author":"Zenouzi","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.cld.2015.08.011_bib23","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.cld.2015.08.011_bib24","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/lt.23587","article-title":"Risk of waitlist mortality in patients with primary sclerosing cholangitis and bacterial cholangitis","volume":"19","author":"Goldberg","year":"2013","journal-title":"Liver Transpl"},{"issue":"11","key":"10.1016\/j.cld.2015.08.011_bib25","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1002\/lt.22396","article-title":"Waitlist survival of patients with primary sclerosing cholangitis in the model for end-stage liver disease era","volume":"17","author":"Goldberg","year":"2011","journal-title":"Liver Transpl"},{"issue":"6","key":"10.1016\/j.cld.2015.08.011_bib26","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.26565","article-title":"Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis","volume":"58","author":"Boonstra","year":"2013","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2015.08.011_bib27","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000347207","article-title":"Liver transplantation for perihilar cholangiocarcinoma","volume":"31","author":"Gores","year":"2013","journal-title":"Dig Dis"},{"issue":"10 Suppl 2","key":"10.1016\/j.cld.2015.08.011_bib28","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1002\/lt.20266","article-title":"Transplantation for hilar cholangiocarcinoma","volume":"10","author":"Heimbach","year":"2004","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.cld.2015.08.011_bib29","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1091-255X(99)80051-1","article-title":"Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis","volume":"3","author":"Ahrendt","year":"1999","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"1","key":"10.1016\/j.cld.2015.08.011_bib30","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.gastro.2012.04.008","article-title":"Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12\u00a0US centers","volume":"143","author":"Darwish Murad","year":"2012","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cld.2015.08.011_bib31","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1600-6143.2004.00703.x","article-title":"The survival benefit of liver transplantation","volume":"5","author":"Merion","year":"2005","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.cld.2015.08.011_bib32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2003.50016","article-title":"Model for end-stage liver disease (MELD) and allocation of donor livers","volume":"124","author":"Wiesner","year":"2003","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cld.2015.08.011_bib33","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1053\/jlts.2003.50090","article-title":"MELD score predicts 1-year patient survival post-orthotopic liver transplantation","volume":"9","author":"Saab","year":"2003","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.cld.2015.08.011_bib34","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A\u00a0model to predict survival in patients with end-stage liver disease","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.cld.2015.08.011_bib35","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1097\/TP.0b013e31821694b3","article-title":"Current trends in living donor liver transplantation for primary sclerosing cholangitis","volume":"91","author":"Goldberg","year":"2011","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.cld.2015.08.011_bib36","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1111\/j.1600-6143.2011.03969.x","article-title":"Lack of standardization in exception points for patients with primary sclerosing cholangitis and bacterial cholangitis","volume":"12","author":"Goldberg","year":"2012","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.cld.2015.08.011_bib37","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/lt.22218","article-title":"Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk","volume":"17","author":"Somsouk","year":"2011","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.cld.2015.08.011_bib38","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s40472-014-0027-4","article-title":"Standardizing MELD exceptions: current challenges and future directions","volume":"1","author":"Goldberg","year":"2014","journal-title":"Curr Transplant Rep"},{"issue":"5","key":"10.1016\/j.cld.2015.08.011_bib39","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.cgh.2013.02.014","article-title":"Model for end-stage liver disease-based organ allocation: managing the exceptions to the rules","volume":"11","author":"Goldberg","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12 Suppl 3","key":"10.1016\/j.cld.2015.08.011_bib40","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.1002\/lt.20979","volume":"12","author":"Freeman","year":"2006","journal-title":"Liver Transpl"},{"issue":"4 Pt 2","key":"10.1016\/j.cld.2015.08.011_bib41","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/j.1600-6143.2010.03037.x","article-title":"Liver transplantation in the United States, 1999-2008","volume":"10","author":"Thuluvath","year":"2010","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.cld.2015.08.011_bib42","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1002\/hep.27307","article-title":"Superior survival using living donors and donor-recipient matching using a novel living donor risk index","volume":"60","author":"Goldberg","year":"2014","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2015.08.011_bib43","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/hep.510290427","article-title":"Recurrence of primary sclerosing cholangitis following liver transplantation","volume":"29","author":"Graziadei","year":"1999","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2015.08.011_bib44","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1600-6143.2010.03402.x","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation in Japanese registry","volume":"11","author":"Egawa","year":"2011","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.cld.2015.08.011_bib45","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1432-2277.2008.00729.x","article-title":"Autoimmune liver diseases and recurrence after orthotopic liver transplantation: what have we learned so far?","volume":"22","author":"Schreuder","year":"2009","journal-title":"Transpl Int"},{"issue":"7","key":"10.1016\/j.cld.2015.08.011_bib46","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1053\/jlts.2003.50143","article-title":"Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation","volume":"9","author":"Kugelmas","year":"2003","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1016\/j.cld.2015.08.011_bib47","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cgh.2012.12.027","article-title":"Immunosuppression after liver transplantation for primary sclerosing cholangitis influences activity of inflammatory bowel disease","volume":"11","author":"Jorgensen","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2015.08.011_bib48","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1478-3231.2011.02677.x","article-title":"The impact of inflammatory bowel disease post-liver transplantation for primary sclerosing cholangitis","volume":"33","author":"Joshi","year":"2013","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.cld.2015.08.011_bib49","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1155\/2010\/830291","article-title":"The natural history of inflammatory bowel disease and primary sclerosing cholangitis after liver transplantation\u2013a single-centre experience","volume":"24","author":"Moncrief","year":"2010","journal-title":"Can J Gastroenterol"},{"issue":"9","key":"10.1016\/j.cld.2015.08.011_bib50","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/ajg.2013.163","article-title":"Inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis","volume":"108","author":"Singh","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"17","key":"10.1016\/j.cld.2015.08.011_bib51","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2011.1592","article-title":"Spectrum of cancer risk among US solid organ transplant recipients","volume":"306","author":"Engels","year":"2011","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.cld.2015.08.011_bib52","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1097\/01.TP.0000058744.34965.38","article-title":"Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis","volume":"75","author":"Vera","year":"2003","journal-title":"Transplantation"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326115000835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326115000835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T08:09:43Z","timestamp":1599725383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326115000835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S1089326115000835"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2015.08.011","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver Transplantation for Cholestatic Liver Diseases in Adults","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2015.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}